Observational study of homeopathic and conventional therapies in patients with diabetic polyneuropathy

Methods: The feasibility and outcomes of homeopathic therapy in a group of type-2 diabetes mellitus patients with diabetic neuropathy were studied in a prospective observational study. Patients were followed from baseline (T0) for 6 months (T1) and for 12 months (T2), treatment was adjusted as necessary. Primary outcome was diabetic neuropathy symptom (DNS) score, secondary outcomes were clinical evolution and short-form-36 (SF-36)-evaluated quality of life (QOL).

Results: Homeopathy was used in 45 patients, 32 of whom completed the observation study, and in parallel the conventional therapy outcomes were observed in 32 patients, 29 of whom completed the study. DNS improved in both groups during the observation period, but the change with respect to baseline was statistically significant only in Homeopathic group at T1 (P = 0.016). Over the course of the observation there was a substantial stability of the electroneurophysiological values, blood pressure and body weight in both groups, a slight decrease of fasting blood glucose and glycated haemoglobin in Homeopathic group. QOL scores showed an improvement in Homeopathic group only. The cost of conventional drugs decreased in Homeopathic group from 114 €/month to 94 €/month at T1.

Conclusion: Complementary homeopathic therapy of diabetic neuropathy was feasible and promising effects in symptom scores and cost savings were observed.

Keywords

diabetes - diabetic neuropathy - homeopathy - observational study - quality of life - pharmacoeconomics

• References

• 1 Muscari-Tomaioli G., Allegri F., Miali E. et al. Observational study of quality of life in patients with headache, receiving homeopathic treatment. Br Homeopath J 2001; 90 (04) 189-197.
• 2 Thompson E.A., Reilly D. The homeopathic approach to symptom control in the cancer patient: a prospective observational study. Palliat Med 2002; 16 (03) 227-233.
• 3 Van Wassenhoven M., Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy 2004; 93 (01) 3-11.
• 4 Steinsbekk A., Ludtke R. Patients' assessments of the effectiveness of homeopathic care in Norway: a prospective observational multicentre outcome study. Homeopathy 2005; 94 (01) 10-16.
• 5 Spence D.S., Thompson E.A., Barron S.J. Homeopathic treatment for chronic disease: a 6-year, university-hospital outpatient observational study. J Altern Complement Med 2005; 11 (05) 793-798.
• 6 Mathie R.T., Robinson T.W. Outcomes from homeopathic prescribing in medical practice: a prospective, research-targeted, pilot study. Homeopathy 2006; 95 (04) 199-205.
• 7 Vithoulkas G. The science of homeopathy. New York: Grove Press Inc.; 1980.
• 8 Bellavite P. Complexity science and homeopathy. A synthetic overview. Homeopathy 2003; 92: 203-212.
• 9 Bell I.R., Koithan M. Models for the study of whole systems. Integr Cancer Ther 2006; 5 (04) 293-307.
• 10 Pomposelli R., Codecà G., Bergonzi R. et al. Terapia omeopatica in pazienti con patologia artroreumatica. Medicina Naturale 2003; 13: 44-50.
• 11 Ware Jr. J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30 (06) 473-483.
• 12 Garratt A.M., Ruta D.A., Abdalla M.I., Buckingham J.K., Russell I.T. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?. Br Med J 1993; 306 (6890): 1440-1444.
• 13 Apolone G., Mosconi P. The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 1998; 51: 1025-1036.
• 14 Brazier J.E., Harper R., Jones N.M. et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 1992; 305 (6846): 160-164.
• 15 Walach H., Guthlin C. Effects of acupuncture and homeopathy: prospective documentation. Interim results. Br Homeopath J 2000; 89: S31-S34.
• 16 Guthlin C., Lange O., Walach H. Measuring the effects of acupuncture and homoeopathy in general practice: an uncontrolled prospective documentation approach. BMC Public Health 2004; 4 (01) 6.
• 17 Meijer J.W., Smit A.J., Sonderen E.V., Groothoff J.W., Eisma W.H., Links T.P. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med 2002; 19 (11) 962-965.
• 18 Apolone G., Mosconi P., Ware Jr. J.E. Questionario sullo stato di salute SF-36. Manuale d'uso e interpretazione dei risultati. Milano: Guerini e Ass.; 1997.
• 19 Mingardi G., Cornalba L., Cortinovis E., Ruggiata R., Mosconi P., Apolone G. Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant 1999; 14 (06) 1503-1510.
• 20 Everitt B.S., Dunn G. Statistical analysis of medical data. London: Arnold; 1998.
• 21 Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum; 1987.
• 22 Oberbaum M., Vithoulkas G., van Haselen R. Clinical trials of classical homeopathy: reflections on appropriate research designs. J Altern Complement Med 2003; 9 (01) 105-111.
• 23 Walach H., Falkenberg T., Fonnebo V., Lewith G., Jonas W.B. Circular instead of hierarchical: methodological principles for the evaluation of complex interventions. BMC Med Res Methodol 2006; 6: 29.
• 24 Hahnemann C.F.S. Organon of medicine. Edited from the 5th and 6th edition (1842) by Joseph Reves Haifa: Homeopress Ltd; 1994.
• 25 Teut M. Homeopathy between vital force and self-organization. Forsch Komplementarmed Klass Naturheilkd 2001; 8 (03) 162-167.
• 26 Bell I.R., Lewis D.A., Lewis S.E., Brooks A.J., Schwartz G.E., Baldwin C.M. Strength of vital force in classical homeopathy: bio-psycho-social-spiritual correlates within a complex systems context. J Altern Complement Med 2004; 10 (01) 123-131.